HUP9702359A3 - Monoclonal antibody, method of preparing a monoclonal antibody, and pharmaceutical composition and a diagnostic reagent comprising the monoclonal antibody - Google Patents
Monoclonal antibody, method of preparing a monoclonal antibody, and pharmaceutical composition and a diagnostic reagent comprising the monoclonal antibodyInfo
- Publication number
- HUP9702359A3 HUP9702359A3 HU9702359A HUP9702359A HUP9702359A3 HU P9702359 A3 HUP9702359 A3 HU P9702359A3 HU 9702359 A HU9702359 A HU 9702359A HU P9702359 A HUP9702359 A HU P9702359A HU P9702359 A3 HUP9702359 A3 HU P9702359A3
- Authority
- HU
- Hungary
- Prior art keywords
- monoclonal antibody
- preparing
- pharmaceutical composition
- diagnostic reagent
- monoclonal
- Prior art date
Links
- 239000003153 chemical reaction reagent Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/042—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers characterised by the nature of the carrier
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
- C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/74—Inducing cell proliferation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
- G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
- G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Pain & Pain Management (AREA)
- Pathology (AREA)
- Rheumatology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Transplantation (AREA)
- General Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Mycology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96203465 | 1996-12-06 | ||
| EP97201972 | 1997-06-27 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HU9702359D0 HU9702359D0 (en) | 1998-03-02 |
| HUP9702359A2 HUP9702359A2 (hu) | 1998-09-28 |
| HUP9702359A3 true HUP9702359A3 (en) | 2001-11-28 |
Family
ID=26143410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9702359A HUP9702359A3 (en) | 1996-12-06 | 1997-12-05 | Monoclonal antibody, method of preparing a monoclonal antibody, and pharmaceutical composition and a diagnostic reagent comprising the monoclonal antibody |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US6020170A (hu) |
| EP (1) | EP0856520B1 (hu) |
| JP (1) | JPH10179160A (hu) |
| KR (1) | KR100543053B1 (hu) |
| AT (1) | ATE322507T1 (hu) |
| AU (1) | AU733165B2 (hu) |
| BR (1) | BR9706236A (hu) |
| CA (1) | CA2221682C (hu) |
| DE (1) | DE69735621T2 (hu) |
| DK (1) | DK0856520T3 (hu) |
| ES (1) | ES2262170T3 (hu) |
| HU (1) | HUP9702359A3 (hu) |
| IL (1) | IL122233A (hu) |
| NO (1) | NO327047B1 (hu) |
| NZ (1) | NZ329314A (hu) |
| PL (1) | PL193821B1 (hu) |
| PT (1) | PT856520E (hu) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69934250T2 (de) * | 1998-12-22 | 2007-05-24 | Raven Biotechnologies, Inc., South San Francisco | Zusammensetzungen und verfahren zur herstellung monoklonaler antikörper, repräsentativ für einen spezifischen zelltyp |
| SE9902817D0 (sv) | 1999-07-30 | 1999-07-30 | A & Science Invest Ab | A method for selective electrofusion of at least two fusion partners having cell-like membranes |
| TR200201036T2 (tr) * | 1999-10-18 | 2002-08-21 | Akzo Nobel N.V. | İmmünoterapide kullanmak için değiştirilmiş peptitler ve peptido-taklitleri |
| US6541225B1 (en) | 2000-01-26 | 2003-04-01 | Raven Biotechnologies, Inc. | Methods and compositions for generating human monoclonal antibodies |
| IL154000A0 (en) | 2000-08-14 | 2003-07-31 | Akzo Nobel Nv | Use of antibodies against specific mhc-peptide complexes |
| BR0211468A (pt) * | 2001-07-24 | 2004-11-23 | Univ Yale | Métodos de tratar e de prevenir uma doença inflamátoria em um mamìfero e de identificar um composto útil para tratar uma doença inflamatória em um mamìfero, composto, e kits para tratar e para prevenir uma doença inflamatória em um mamìfero |
| US7018819B2 (en) * | 2001-11-30 | 2006-03-28 | Cellectricon Ab | Method and apparatus for manipulation of cells and cell-like structures focused electric fields in microfludic systems and use thereof |
| WO2004087911A1 (ja) * | 2003-03-28 | 2004-10-14 | Toyama New Industry Organization | １個の抗原特異的ｂリンパ球を用いた抗原特異的抗体産生ハイブリドーマの作製方法及びモノクローナル抗体の製造方法 |
| JP4934426B2 (ja) | 2003-08-18 | 2012-05-16 | メディミューン，エルエルシー | 抗体のヒト化 |
| US20060228350A1 (en) * | 2003-08-18 | 2006-10-12 | Medimmune, Inc. | Framework-shuffling of antibodies |
| WO2005081980A2 (en) * | 2004-02-25 | 2005-09-09 | Medimmune, Inc. | Methods and compositions relating to chitinases and chitinase-like molecules and modulation of osteoclasts |
| CA2595682A1 (en) * | 2005-01-31 | 2006-08-03 | Ablynx N.V. | Method for generating variable domain sequences of heavy chain antibodies |
| EP1869192B1 (en) | 2005-03-18 | 2016-01-20 | MedImmune, LLC | Framework-shuffling of antibodies |
| US20070110757A1 (en) | 2005-06-23 | 2007-05-17 | Ziping Wei | Antibody formulations having optimized aggregation and fragmentation profiles |
| WO2007027748A2 (en) * | 2005-08-31 | 2007-03-08 | Medimmune, Inc. | C/clp antagonists and methods of use thereof |
| ES2537205T3 (es) * | 2008-01-09 | 2015-06-03 | Alcon Lensx, Inc. | Fragmentación de tejido por láser fotodisruptor |
| US20160075766A1 (en) | 2013-05-21 | 2016-03-17 | Roche Diagnostics Operations, Inc. | Method for producing antibodies using ovine b-cells and uses thereof |
| WO2019105864A1 (en) | 2017-11-30 | 2019-06-06 | F. Hoffmann-La Roche Ag | B-cell cultivation method |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4550086A (en) * | 1983-02-16 | 1985-10-29 | Dana-Farber Cancer Institute, Inc. | Monoclonal antibodies that recognize human T cells |
| EP0255547A1 (en) * | 1986-07-29 | 1988-02-10 | Kishimoto, Tadamitsu, Prof. | Monoclonal antibodies specific to surface receptor for IgE and hybrid cell lines producing these antibodies and use thereof |
| US5223426A (en) * | 1988-12-15 | 1993-06-29 | T Cell Sciences, Inc. | Monoclonal antibodies reactive with defined regions of the t-cell antigen receptor |
| US5766947A (en) * | 1988-12-14 | 1998-06-16 | Astra Ab | Monoclonal antibodies reactive with an epitope of a Vβ3.1 variable region of a T cell receptor |
| US5162223A (en) * | 1989-02-17 | 1992-11-10 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Resources | Hybridomas and resulting monoclonal antibodies directed against antigens of Bordetella pertussis |
| IE912528A1 (en) * | 1990-07-19 | 1992-01-29 | Scripps Clinic Res | Inhabition of mac-1 receptor binding fibrinogen using d30¹homologs |
| ZA919299B (en) * | 1990-11-26 | 1992-08-26 | Akzo Nv | Method for the production of antibodies |
| EP0889964A1 (en) * | 1996-03-28 | 1999-01-13 | The Johns Hopkins University | Soluble divalent and multivalent heterodimeric analogs of proteins |
-
1997
- 1997-11-18 IL IL12223397A patent/IL122233A/en not_active IP Right Cessation
- 1997-11-25 CA CA2221682A patent/CA2221682C/en not_active Expired - Fee Related
- 1997-11-27 JP JP9363807A patent/JPH10179160A/ja active Pending
- 1997-12-02 ES ES97203769T patent/ES2262170T3/es not_active Expired - Lifetime
- 1997-12-02 EP EP97203769A patent/EP0856520B1/en not_active Expired - Lifetime
- 1997-12-02 PT PT97203769T patent/PT856520E/pt unknown
- 1997-12-02 DE DE69735621T patent/DE69735621T2/de not_active Expired - Lifetime
- 1997-12-02 AT AT97203769T patent/ATE322507T1/de not_active IP Right Cessation
- 1997-12-02 DK DK97203769T patent/DK0856520T3/da active
- 1997-12-03 NZ NZ329314A patent/NZ329314A/xx unknown
- 1997-12-04 BR BR9706236A patent/BR9706236A/pt active Search and Examination
- 1997-12-05 PL PL323572A patent/PL193821B1/pl not_active IP Right Cessation
- 1997-12-05 AU AU46908/97A patent/AU733165B2/en not_active Ceased
- 1997-12-05 NO NO19975714A patent/NO327047B1/no not_active IP Right Cessation
- 1997-12-05 HU HU9702359A patent/HUP9702359A3/hu unknown
- 1997-12-05 KR KR1019970066848A patent/KR100543053B1/ko not_active IP Right Cessation
- 1997-12-05 US US08/985,898 patent/US6020170A/en not_active Expired - Lifetime
-
1999
- 1999-09-27 US US09/405,745 patent/US6392020B1/en not_active Expired - Lifetime
-
2001
- 2001-11-01 US US09/985,065 patent/US20020143150A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| MX9709446A (es) | 1998-07-31 |
| HU9702359D0 (en) | 1998-03-02 |
| IL122233A (en) | 2001-04-30 |
| AU4690897A (en) | 1998-06-11 |
| CA2221682C (en) | 2011-10-18 |
| EP0856520A1 (en) | 1998-08-05 |
| JPH10179160A (ja) | 1998-07-07 |
| AU733165B2 (en) | 2001-05-10 |
| PL193821B1 (pl) | 2007-03-30 |
| US20020143150A1 (en) | 2002-10-03 |
| NO975714L (no) | 1998-06-08 |
| ES2262170T3 (es) | 2006-11-16 |
| PL323572A1 (en) | 1998-06-08 |
| KR19980063909A (ko) | 1998-10-07 |
| BR9706236A (pt) | 1999-05-04 |
| KR100543053B1 (ko) | 2006-06-13 |
| ATE322507T1 (de) | 2006-04-15 |
| NO327047B1 (no) | 2009-04-14 |
| PT856520E (pt) | 2006-08-31 |
| US6392020B1 (en) | 2002-05-21 |
| NZ329314A (en) | 1999-02-25 |
| EP0856520B1 (en) | 2006-04-05 |
| US6020170A (en) | 2000-02-01 |
| DE69735621T2 (de) | 2006-08-24 |
| NO975714D0 (no) | 1997-12-05 |
| DK0856520T3 (da) | 2006-07-31 |
| CA2221682A1 (en) | 1998-06-06 |
| HUP9702359A2 (hu) | 1998-09-28 |
| IL122233A0 (en) | 1998-04-05 |
| DE69735621D1 (de) | 2006-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU3779695A (en) | Interferon-gamma production inducing polypeptide, monoclonal antibody, and agent for interferon-gamma susceptive disease | |
| HUP9702359A3 (en) | Monoclonal antibody, method of preparing a monoclonal antibody, and pharmaceutical composition and a diagnostic reagent comprising the monoclonal antibody | |
| PL311926A1 (en) | Anti-alphav-integrinic monoclonal antibodies | |
| PL330111A1 (en) | Concentyratyed antibody preparation | |
| EP0842948A4 (en) | ANTIBODIES OF LIGAND ANTIFas AND METHOD OF TESTING USING SAME | |
| HK1015282A1 (en) | High affinity human monoclonal antibodies specificfor rsv f-protein. | |
| EP0341684A3 (en) | Human monoclonal antibody, hybridoma producing the same and pharmaceutical | |
| AU7625898A (en) | Method and reagent for the treatment of a disease associated with interleukin-2 receptor gamma-chain expression | |
| AU2696495A (en) | Method for determining hiv-1 antigen and antibody | |
| EP0909278A4 (en) | IMMUNOGLOBULIN G LINKED TO NEPHROPATHY AND ANTIBODIES AGAINST IT | |
| IL109232A0 (en) | Human monoclonal antibodies and processes and materials for making such antibodies | |
| ZA9710391B (en) | Method of preparing a monoclonal antibody, monoclonal antibody, a pharmaceutical composition and a diagnostic reagent. | |
| EP0613899A3 (en) | Cocaine derivative, its protein conjugate, cell line producing monoclonal antibodies, cell line production method and monoclonal antibodies. | |
| AU1042488A (en) | Bilirubin antigen, monoclonal antibody therefor, process for their preparation, and their use | |
| IL96369A0 (en) | Decapeptide,monoclonal antibodies directed thereto and their use in diagnosis | |
| AU3257399A (en) | Monoclonal antibodies esm-1 protein specific, and use of said antibodies for detecting esm-1 protein | |
| IL83342A0 (en) | Monoclonal antibodies,their preparation and their use | |
| AU7128098A (en) | Methods of obtaining antigens specific for fungi, antibodies for such antigens, and diagnosis of disease using such antigens and/or antibodies | |
| ZA941645B (en) | Antibodies specifically reactive against human prostate specific antigen. | |
| EP0485476A4 (en) | Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof | |
| AU1809695A (en) | Tumor associated monoclonal antibody 123av16 | |
| GB9718911D0 (en) | Monoclonal antibodies | |
| GB8927389D0 (en) | Monoclonal antibodies | |
| GB2267148B (en) | Footrot antigens,vaccines and diagnostic assays | |
| GB9509004D0 (en) | Antibodies, preparation, use and method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB9A | Succession in title |
Owner name: N.V. ORGANON, NL Free format text: FORMER OWNER(S): AKZO NOBEL N.V., NL |
|
| FD9A | Lapse of provisional protection due to non-payment of fees |